{"nct_id":"NCT01502020","title":"A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses","status":"COMPLETED","status_verified_date":"2011-12","start_date":"2011-02","start_date_type":null,"primary_completion_date":"2011-08","primary_completion_date_type":"ACTUAL","completion_date":"2011-11","completion_date_type":"ACTUAL","phases":["NA"],"tickers":["TEVA"]}